Novira Therapeutics Garners $7,500,000 Series A Funding Round

  • Feed Type
  • Date
    3/26/2013
  • Company Name
    Novira Therapeutics
  • Mailing Address
    Undisclosed Los Angeles, CA 90041
  • Company Description
    Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is led by seasoned pharmaceutical industry executives with proven records of success in drug discovery. The company has identified and is further optimizing a promising pipeline of drugs that disrupt virus capsid assembly of HIV and HBV using an efficient and innovative model of biomedical research.
  • Website
    http://www.noviratherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We plan to use these funds to advance development of our hepatitis B virus (HBV) capsid inhibitor lead program toward the clinic and to discover additional HBV drug candidates.
  • M&A Terms
  • Venture Investor
    Versant Ventures

By posting a comment, you agree to our terms and conditions.